1 INTRODUCTION
1.1 REPORT DESCRIPTION
1.2 RESEARCH METHODOLOGY
1.2.1 SECONDARY RESEARCH
1.2.2 DATA ANALYSIS FRAMEWORK
1.2.3 MARKET SIZE ESTIMATION
1.2.4 FORECASTING
1.2.5 PRIMARY RESEARCH AND DATA VALIDATION
2 NORTH AMERICA PATIENT MONITORING MARKET – EXECUTIVE SUMMARY
2.1. MARKET SNAPSHOT, 2023 - 2030, Million USD
3 PORTER’S FIVE FORCE MODEL ANALYSIS
3.1 BARGAINING POWER OF SUPPLIERS
3.2 BARGAINING POWER OF BUYERS
3.3 DEGREE OF COMPETITION
3.4 THREAT OF SUBSTITUTE
3.5 THREAT OF NEW ENTRANTS
4 MARKET SHARE ANALYSIS
4.1 MARKET SHARE ANALYSIS OF TOP PROVIDERS, 2023
5 MARKET DYNAMICS
5.1 GROWTH DRIVERS
5.1.1 DRIVER 1
5.1.2 DRIVER 2
5.1.3 DRIVER 3
5.1.4 DRIVER 4
5.2 CHALLENGES
5.2.1 CHALLENGE 1
5.2.2 CHALLENGE 2
5.2.3 CHALLENGE 3
5.2.4 CHALLENGE 4
5.3 OPPORTUNITIES
5.3.1 OPPORTUNITY 1
5.3.2 OPPORTUNITY 2
6 NORTH AMERICA PATIENT MONITORING MARKET BY PRODUCT
6.1 OVERVIEW
6.2 CARDIAC MONITORING DEVICES
6.2.1 CARDIAC MONITORING DEVICES MARKET, BY PRODUCT
6.2.1.1 Mobile Cardiac Telemetry Monitors Market, By Country
6.2.1.2 Electrocardiogram (ECG) Devices Market, By Country
6.2.1.3 Implantable Loop Recorders Market, By Country
6.2.1.4 Event Monitors Market, By Country
6.2.1.5 Smart/Wearable ECG Monitors Market, By Country
6.2.2 CARDIAC MONITORING DEVICES MARKET, BY COUNTRY
6.3 BLOOD GLUCOSE MONITORING SYSTEMS
6.3.1 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT
6.3.1.1 Self-Monitoring Blood Glucose Systems Market, By Country
6.3.1.2 Continuous Glucose Monitoring Systems Market, By Country
6.3.2 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY
6.4 HEMODYNAMIC/PRESSURE MONITORING DEVICES
6.4.1 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY PRODUCT
6.4.1.1 Hemodynamic Monitors Market, By Country
6.4.1.2 Blood Pressure Monitors Market, By Country
6.4.1.3 Disposables Market, By Country
6.4.2 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY COUNTRY
6.5 MULTI-PARAMETER MONITORING DEVICES
6.5.1 MULTI-PARAMETER MONITORING DEVICES MARKET, BY PRODUCT
6.5.1.1 Low-Acuity Monitoring Device Market, By Country
6.5.1.2 Mid-Acuity Monitoring Devices Market, By Country
6.5.1.3 High-Acuity Monitoring Devices Market, By Country
6.5.2 MULTI-PARAMETER MONITORING DEVICES MARKET, BY COUNTRY
6.6 RESPIRATORY MONITORING DEVICES
6.6.1 RESPIRATORY MONITORING DEVICES MARKET, BY PRODUCT
6.6.1.1 Pulse Oximeters Market, By Country
6.6.1.2 Spirometers Market, By Country
6.6.1.3 Capnographs Market, By Country
6.6.1.4 Peak Flow Meters Market, By Country
6.6.2 RESPIRATORY MONITORING DEVICES MARKET, BY COUNTRY
6.7 TEMPERATURE MONITORING DEVICE
6.7.1 TEMPERATURE MONITORING DEVICE MARKET, BY PRODUCT
6.7.1.1 Handheld Temperature Monitoring Devices Market, By Country
6.7.1.2 Table-Top Temperature Monitoring Devices Market, By Country
6.7.1.3 Wearable Continuous Monitoring Devices Market, By Country
6.7.1.4 Invasive Temperature Monitoring Devices Market, By Country
6.7.1.5 Smart Temperature Monitoring Devices Market, By Country
6.7.2 TEMPERATURE MONITORING DEVICE MARKET, BY COUNTRY
6.8 FETAL AND NEONATAL MONITORING DEVICES
6.8.1 FETAL AND NEONATAL MONITORING DEVICES MARKET, BY PRODUCT
6.8.1.1 Neonatal Monitoring Devices Market, By Country
6.8.1.2 Fetal Monitoring Devices Market, By Country
6.8.2 FETAL AND NEONATAL MONITORING DEVICES MARKET, BY COUNTRY
6.9 NEUROMONITORING DEVICES
6.9.1 NEUROMONITORING DEVICES MARKET, BY PRODUCT
6.9.1.1 Electroencephalograph (EEG) Machines Market, By Country
6.9.1.2 Electromyography Machines Market, By Country
6.9.1.3 Cerebral Oximeter Market, By Country
6.9.1.4 Intracranial Pressure (ICP) Monitors Market, By Country
6.9.1.5 Magnetoencephalography (MEG) Machines Market, By Country
6.9.1.6 Transcranial Doppler (TCD) Machines Market, By Country
6.9.2 NEUROMONITORING DEVICES MARKET, BY COUNTRY
6.10 WEIGHT MONITORING DEVICES
6.10.1 WEIGHT MONITORING DEVICES MARKET, BY PRODUCT
6.10.1.1 Digital Market, By Country
6.10.1.2 Analog Market, By Country
6.10.2 WEIGHT MONITORING DEVICES MARKET, BY COUNTRY
6.11 OTHERS DEVICES
6.11.1 OTHERS DEVICES MARKET, BY COUNTRY
7 NORTH AMERICA PATIENT MONITORING MARKET BY TYPE
7.1 OVERVIEW
7.2 CONVENTIONAL
7.2.1 CONVENTIONAL MARKET, BY COUNTRY
7.3 WIRELESS
7.3.1 WIRELESS MARKET, BY COUNTRY
8 NORTH AMERICA PATIENT MONITORING MARKET BY END USER
8.1 OVERVIEW
8.2 HOME HEALTHCARE
8.2.1 HOME HEALTHCARE MARKET, BY COUNTRY
8.3 HOSPITALS AND CLINICS
8.3.1 HOSPITALS AND CLINICS MARKET, BY COUNTRY
8.4 OTHERS
8.4.1 OTHERS MARKET, BY COUNTRY
9 NORTH AMERICA PATIENT MONITORING MARKET, BY COUNTRY
9.1 OVERVIEW
9.2 UNITED STATES
9.2.1 NORTH AMERICA PATIENT MONITORING MARKET, BY PRODUCT
9.2.2 NORTH AMERICA PATIENT MONITORING MARKET, BY TYPE
9.2.3 NORTH AMERICA PATIENT MONITORING MARKET, BY END USER
9.3 CANADA
9.3.1 NORTH AMERICA PATIENT MONITORING MARKET, BY PRODUCT
9.3.2 NORTH AMERICA PATIENT MONITORING MARKET, BY TYPE
9.3.3 NORTH AMERICA PATIENT MONITORING MARKET, BY END USER
9.4 MEXICO
9.4.1 NORTH AMERICA PATIENT MONITORING MARKET, BY PRODUCT
9.4.2 NORTH AMERICA PATIENT MONITORING MARKET, BY TYPE
9.4.3 NORTH AMERICA PATIENT MONITORING MARKET, BY END USER
10 COMPANY PROFILES
10.1 MEDTRONIC PLC
10.1.1 COMPANY OVERVIEW
10.1.2 COMPANY SNAPSHOT
10.1.3 OPERATING BUSINESS SEGMENTS
10.1.4 PRODUCT PORTFOLIO
10.1.5 BUSINESS PERFORMANCE
10.1.6 BUSINESS SEGMENTS
10.1.7 GEOGRAPHIC SEGMENTS
10.1.8 KEY STRATEGIC MOVES AND DEVELOPMENT
10.1.9 PRIMARY MARKET COMPETITORS
10.2 KONINKLIJKE PHILIPS N.V.
10.2.1 COMPANY OVERVIEW
10.2.2 COMPANY SNAPSHOT
10.2.3 OPERATING BUSINESS SEGMENTS
10.2.4 PRODUCT PORTFOLIO
10.2.5 BUSINESS PERFORMANCE
10.2.6 BUSINESS SEGMENTS
10.2.7 GEOGRAPHIC SEGMENTS
10.2.8 KEY STRATEGIC MOVES AND DEVELOPMENT
10.2.9 PRIMARY MARKET COMPETITORS
10.3 GE HEALTHCARE
10.3.1 COMPANY OVERVIEW
10.3.2 COMPANY SNAPSHOT
10.3.3 OPERATING BUSINESS SEGMENTS
10.3.4 PRODUCT PORTFOLIO
10.3.5 BUSINESS PERFORMANCE
10.3.6 BUSINESS SEGMENTS
10.3.7 GEOGRAPHIC SEGMENTS
10.3.8 KEY STRATEGIC MOVES AND DEVELOPMENT
10.3.9 PRIMARY MARKET COMPETITORS
10.4 SIEMENS HEALTHINEERS
10.4.1 COMPANY OVERVIEW
10.4.2 COMPANY SNAPSHOT
10.4.3 OPERATING BUSINESS SEGMENTS
10.4.4 PRODUCT PORTFOLIO
10.4.5 BUSINESS PERFORMANCE
10.4.6 BUSINESS SEGMENTS
10.4.7 GEOGRAPHIC SEGMENTS
10.4.8 KEY STRATEGIC MOVES AND DEVELOPMENT
10.4.9 PRIMARY MARKET COMPETITORS
10.5 NIHON KOHDEN CORPORATION
10.5.1 COMPANY OVERVIEW
10.5.2 COMPANY SNAPSHOT
10.5.3 OPERATING BUSINESS SEGMENTS
10.5.4 PRODUCT PORTFOLIO
10.5.5 BUSINESS PERFORMANCE
10.5.6 BUSINESS SEGMENTS
10.5.7 GEOGRAPHIC SEGMENTS
10.5.8 KEY STRATEGIC MOVES AND DEVELOPMENT
10.5.9 PRIMARY MARKET COMPETITORS
10.6 ABBOTT LABORATORIES
10.6.1 COMPANY OVERVIEW
10.6.2 COMPANY SNAPSHOT
10.6.3 OPERATING BUSINESS SEGMENTS
10.6.4 PRODUCT PORTFOLIO
10.6.5 BUSINESS PERFORMANCE
10.6.6 BUSINESS SEGMENTS
10.6.7 GEOGRAPHIC SEGMENTS
10.6.8 KEY STRATEGIC MOVES AND DEVELOPMENT
10.6.9 PRIMARY MARKET COMPETITORS
10.7 MASIMO CORPORATION
10.7.1 COMPANY OVERVIEW
10.7.2 COMPANY SNAPSHOT
10.7.3 OPERATING BUSINESS SEGMENTS
10.7.4 PRODUCT PORTFOLIO
10.7.5 BUSINESS PERFORMANCE
10.7.6 BUSINESS SEGMENTS
10.7.7 GEOGRAPHIC SEGMENTS
10.7.8 KEY STRATEGIC MOVES AND DEVELOPMENT
10.7.9 PRIMARY MARKET COMPETITORS
10.8 HILL-ROM HOLDINGS, INC.
10.8.1 COMPANY OVERVIEW
10.8.2 COMPANY SNAPSHOT
10.8.3 OPERATING BUSINESS SEGMENTS
10.8.4 PRODUCT PORTFOLIO
10.8.5 BUSINESS PERFORMANCE
10.8.6 BUSINESS SEGMENTS
10.8.7 GEOGRAPHIC SEGMENTS
10.8.8 KEY STRATEGIC MOVES AND DEVELOPMENT
10.8.9 PRIMARY MARKET COMPETITORS
10.9 BIOTRONIK SE AND CO. KG
10.9.1 COMPANY OVERVIEW
10.9.2 COMPANY SNAPSHOT
10.9.3 OPERATING BUSINESS SEGMENTS
10.9.4 PRODUCT PORTFOLIO
10.9.5 BUSINESS PERFORMANCE
10.9.6 BUSINESS SEGMENTS
10.9.7 GEOGRAPHIC SEGMENTS
10.9.8 KEY STRATEGIC MOVES AND DEVELOPMENT
10.9.9 PRIMARY MARKET COMPETITORS
10.10 HONEYWELL INTERNATIONAL, INC.
10.10.1 COMPANY OVERVIEW
10.10.2 COMPANY SNAPSHOT
10.10.3 OPERATING BUSINESS SEGMENTS
10.10.4 PRODUCT PORTFOLIO
10.10.5 BUSINESS PERFORMANCE
10.10.6 BUSINESS SEGMENTS
10.10.7 GEOGRAPHIC SEGMENTS
10.10.8 KEY STRATEGIC MOVES AND DEVELOPMENT
10.10.9 PRIMARY MARKET COMPETITORS
LIST OF TABLES
TABLE 1. NORTH AMERICA PATIENT MONITORING MARKET VALUE, BY PRODUCT, 2023-2030, (MILLION USD)
TABLE 2. MOBILE CARDIAC TELEMETRY MONITORS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)
TABLE 3. ELECTROCARDIOGRAM (ECG) DEVICES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)
TABLE 4. IMPLANTABLE LOOP RECORDERS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)
TABLE 5. EVENT MONITORS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)
TABLE 6. SMART/WEARABLE ECG MONITORS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)
TABLE 7. CARDIAC MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
TABLE 8. SELF-MONITORING BLOOD GLUCOSE SYSTEMS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)
TABLE 9. CONTINUOUS GLUCOSE MONITORING SYSTEMS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)
TABLE 10. BLOOD GLUCOSE MONITORING SYSTEMS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
TABLE 11. HEMODYNAMIC MONITORS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)
TABLE 12. BLOOD PRESSURE MONITORS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)
TABLE 13. DISPOSABLES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)
TABLE 14. HEMODYNAMIC/PRESSURE MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
TABLE 15. LOW-ACUITY MONITORING DEVICE, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)
TABLE 16. MID-ACUITY MONITORING DEVICES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)
TABLE 17. HIGH-ACUITY MONITORING DEVICES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)
TABLE 18. MULTI-PARAMETER MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
TABLE 19. PULSE OXIMETERS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)
TABLE 20. SPIROMETERS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)
TABLE 21. CAPNOGRAPHS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)
TABLE 22. PEAK FLOW METERS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)
TABLE 23. RESPIRATORY MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
TABLE 24. HANDHELD TEMPERATURE MONITORING DEVICES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)
TABLE 25. TABLE-TOP TEMPERATURE MONITORING DEVICES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)
TABLE 26. WEARABLE CONTINUOUS MONITORING DEVICES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)
TABLE 27. INVASIVE TEMPERATURE MONITORING DEVICES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)
TABLE 28. SMART TEMPERATURE MONITORING DEVICES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)
TABLE 29. TEMPERATURE MONITORING DEVICE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
TABLE 30. NEONATAL MONITORING DEVICES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)
TABLE 31. FETAL MONITORING DEVICES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)
TABLE 32. FETAL AND NEONATAL MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
TABLE 33. ELECTROENCEPHALOGRAPH (EEG) MACHINES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)
TABLE 34. ELECTROMYOGRAPHY MACHINES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)
TABLE 35. CEREBRAL OXIMETER, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)
TABLE 36. INTRACRANIAL PRESSURE (ICP) MONITORS, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)
TABLE 37. MAGNETOENCEPHALOGRAPHY (MEG) MACHINES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)
TABLE 38. TRANSCRANIAL DOPPLER (TCD) MACHINES, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)
TABLE 39. NEUROMONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
TABLE 40. DIGITAL, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)
TABLE 41. ANALOG, MARKET VALUE, BY COUNTRY 2023-2030, (MILLION USD)
TABLE 42. WEIGHT MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
TABLE 43. OTHERS DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
TABLE 44. NORTH AMERICA PATIENT MONITORING MARKET VALUE, BY TYPE, 2023-2030, (MILLION USD)
TABLE 45. CONVENTIONAL, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
TABLE 46. WIRELESS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
TABLE 47. NORTH AMERICA PATIENT MONITORING MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)
TABLE 48. HOME HEALTHCARE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
TABLE 49. HOSPITALS AND CLINICS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
TABLE 50. OTHERS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
TABLE 51. NORTH AMERICA PATIENT MONITORING MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
TABLE 52. UNITED STATES NORTH AMERICA PATIENT MONITORING MARKET VALUE, BY PRODUCT, 2023-2030, (MILLION USD)
TABLE 53. UNITED STATES NORTH AMERICA PATIENT MONITORING MARKET VALUE, BY TYPE, 2023-2030, (MILLION USD)
TABLE 54. UNITED STATES NORTH AMERICA PATIENT MONITORING MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)
TABLE 55. CANADA NORTH AMERICA PATIENT MONITORING MARKET VALUE, BY PRODUCT, 2023-2030, (MILLION USD)
TABLE 56. CANADA NORTH AMERICA PATIENT MONITORING MARKET VALUE, BY TYPE, 2023-2030, (MILLION USD)
TABLE 57. CANADA NORTH AMERICA PATIENT MONITORING MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)
TABLE 58. MEXICO NORTH AMERICA PATIENT MONITORING MARKET VALUE, BY PRODUCT, 2023-2030, (MILLION USD)
TABLE 59. MEXICO NORTH AMERICA PATIENT MONITORING MARKET VALUE, BY TYPE, 2023-2030, (MILLION USD)
TABLE 60. MEXICO NORTH AMERICA PATIENT MONITORING MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)
TABLE 61. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 62. MEDTRONIC PLC: OPERATING BUSINESS SEGMENTS
TABLE 63. MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 64. MEDTRONIC PLC: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 65. MEDTRONIC PLC: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 66. MEDTRONIC PLC: KEY STRATERGY
TABLE 67. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
TABLE 68. KONINKLIJKE PHILIPS N.V.: OPERATING BUSINESS SEGMENTS
TABLE 69. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
TABLE 70. KONINKLIJKE PHILIPS N.V.: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 71. KONINKLIJKE PHILIPS N.V.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 72. KONINKLIJKE PHILIPS N.V.: KEY STRATERGY
TABLE 73. GE HEALTHCARE: COMPANY SNAPSHOT
TABLE 74. GE HEALTHCARE: OPERATING BUSINESS SEGMENTS
TABLE 75. GE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 76. GE HEALTHCARE: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 77. GE HEALTHCARE: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 78. GE HEALTHCARE: KEY STRATERGY
TABLE 79. SIEMENS HEALTHINEERS: COMPANY SNAPSHOT
TABLE 80. SIEMENS HEALTHINEERS: OPERATING BUSINESS SEGMENTS
TABLE 81. SIEMENS HEALTHINEERS: PRODUCT PORTFOLIO
TABLE 82. SIEMENS HEALTHINEERS: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 83. SIEMENS HEALTHINEERS: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 84. SIEMENS HEALTHINEERS: KEY STRATERGY
TABLE 85. NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
TABLE 86. NIHON KOHDEN CORPORATION: OPERATING BUSINESS SEGMENTS
TABLE 87. NIHON KOHDEN CORPORATION: PRODUCT PORTFOLIO
TABLE 88. NIHON KOHDEN CORPORATION: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 89. NIHON KOHDEN CORPORATION: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 90. NIHON KOHDEN CORPORATION: KEY STRATERGY
TABLE 91. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 92. ABBOTT LABORATORIES: OPERATING BUSINESS SEGMENTS
TABLE 93. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 94. ABBOTT LABORATORIES: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 95. ABBOTT LABORATORIES: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 96. ABBOTT LABORATORIES: KEY STRATERGY
TABLE 97. MASIMO CORPORATION: COMPANY SNAPSHOT
TABLE 98. MASIMO CORPORATION: OPERATING BUSINESS SEGMENTS
TABLE 99. MASIMO CORPORATION: PRODUCT PORTFOLIO
TABLE 100. MASIMO CORPORATION: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 101. MASIMO CORPORATION: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 102. MASIMO CORPORATION: KEY STRATERGY
TABLE 103. HILL-ROM HOLDINGS, INC.: COMPANY SNAPSHOT
TABLE 104. HILL-ROM HOLDINGS, INC.: OPERATING BUSINESS SEGMENTS
TABLE 105. HILL-ROM HOLDINGS, INC.: PRODUCT PORTFOLIO
TABLE 106. HILL-ROM HOLDINGS, INC.: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 107. HILL-ROM HOLDINGS, INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 108. HILL-ROM HOLDINGS, INC.: KEY STRATERGY
TABLE 109. BIOTRONIK SE AND CO. KG: COMPANY SNAPSHOT
TABLE 110. BIOTRONIK SE AND CO. KG: OPERATING BUSINESS SEGMENTS
TABLE 111. BIOTRONIK SE AND CO. KG: PRODUCT PORTFOLIO
TABLE 112. BIOTRONIK SE AND CO. KG: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 113. BIOTRONIK SE AND CO. KG: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 114. BIOTRONIK SE AND CO. KG: KEY STRATERGY
TABLE 115. HONEYWELL INTERNATIONAL, INC.: COMPANY SNAPSHOT
TABLE 116. HONEYWELL INTERNATIONAL, INC.: OPERATING BUSINESS SEGMENTS
TABLE 117. HONEYWELL INTERNATIONAL, INC.: PRODUCT PORTFOLIO
TABLE 118. HONEYWELL INTERNATIONAL, INC.: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 119. HONEYWELL INTERNATIONAL, INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 120. HONEYWELL INTERNATIONAL, INC.: KEY STRATERGY
LIST OF FIGURES
FIGURE 1. BARGAINING POWER OF SUPPLIERS
FIGURE 2. BARGAINING POWER OF BUYERS
FIGURE 3. DEGREE OF COMPETITION
FIGURE 4. THREAT OF SUBSTITUTE
FIGURE 5. THREAT OF NEW ENTRANTS
FIGURE 6. NORTH AMERICA PATIENT MONITORING MARKET VALUE, BY PRODUCT, 2023-2030, (MILLION USD)
FIGURE 7. MOBILE CARDIAC TELEMETRY MONITORS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 8. ELECTROCARDIOGRAM (ECG) DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 9. IMPLANTABLE LOOP RECORDERS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 10. EVENT MONITORS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 11. SMART/WEARABLE ECG MONITORS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 12. CARDIAC MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 13. SELF-MONITORING BLOOD GLUCOSE SYSTEMS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 14. CONTINUOUS GLUCOSE MONITORING SYSTEMS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 15. BLOOD GLUCOSE MONITORING SYSTEMS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 16. HEMODYNAMIC MONITORS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 17. BLOOD PRESSURE MONITORS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 18. DISPOSABLES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 19. HEMODYNAMIC/PRESSURE MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 20. LOW-ACUITY MONITORING DEVICE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 21. MID-ACUITY MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 22. HIGH-ACUITY MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 23. MULTI-PARAMETER MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 24. PULSE OXIMETERS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 25. SPIROMETERS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 26. CAPNOGRAPHS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 27. PEAK FLOW METERS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 28. RESPIRATORY MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 29. HANDHELD TEMPERATURE MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 30. TABLE-TOP TEMPERATURE MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 31. WEARABLE CONTINUOUS MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 32. INVASIVE TEMPERATURE MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 33. SMART TEMPERATURE MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 34. TEMPERATURE MONITORING DEVICE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 35. NEONATAL MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 36. FETAL MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 37. FETAL AND NEONATAL MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 38. ELECTROENCEPHALOGRAPH (EEG) MACHINES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 39. ELECTROMYOGRAPHY MACHINES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 40. CEREBRAL OXIMETER, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 41. INTRACRANIAL PRESSURE (ICP) MONITORS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 42. MAGNETOENCEPHALOGRAPHY (MEG) MACHINES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 43. TRANSCRANIAL DOPPLER (TCD) MACHINES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 44. NEUROMONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 45. DIGITAL, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 46. ANALOG, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 47. WEIGHT MONITORING DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 48. OTHERS DEVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 49. NORTH AMERICA PATIENT MONITORING MARKET VALUE, BY TYPE, 2023-2030, (MILLION USD)
FIGURE 50. CONVENTIONAL, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 51. WIRELESS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 52. NORTH AMERICA PATIENT MONITORING MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)
FIGURE 53. HOME HEALTHCARE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 54. HOSPITALS AND CLINICS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 55. OTHERS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)
FIGURE 56. NORTH AMERICA PATIENT MONITORING MARKET VALUE, BY REGION 2023-2030, (MILLION USD)
FIGURE 57. UNITED STATES NORTH AMERICA PATIENT MONITORING MARKET VALUE, BY PRODUCT 2023-2030, (MILLION USD)
FIGURE 58. UNITED STATES NORTH AMERICA PATIENT MONITORING MARKET VALUE, BY TYPE 2023-2030, (MILLION USD)
FIGURE 59. UNITED STATES NORTH AMERICA PATIENT MONITORING MARKET VALUE, BY END USER 2023-2030, (MILLION USD)
FIGURE 60. CANADA NORTH AMERICA PATIENT MONITORING MARKET VALUE, BY PRODUCT 2023-2030, (MILLION USD)
FIGURE 61. CANADA NORTH AMERICA PATIENT MONITORING MARKET VALUE, BY TYPE 2023-2030, (MILLION USD)
FIGURE 62. CANADA NORTH AMERICA PATIENT MONITORING MARKET VALUE, BY END USER 2023-2030, (MILLION USD)
FIGURE 63. MEXICO NORTH AMERICA PATIENT MONITORING MARKET VALUE, BY PRODUCT 2023-2030, (MILLION USD)
FIGURE 64. MEXICO NORTH AMERICA PATIENT MONITORING MARKET VALUE, BY TYPE 2023-2030, (MILLION USD)
FIGURE 65. MEXICO NORTH AMERICA PATIENT MONITORING MARKET VALUE, BY END USER 2023-2030, (MILLION USD)
FIGURE 66. MEDTRONIC PLC: NET SALES, (2021-2023)
FIGURE 67. MEDTRONIC PLC: PRIMARY MARKET COMPETITORS
FIGURE 68. KONINKLIJKE PHILIPS N.V.: NET SALES, (2021-2023)
FIGURE 69. KONINKLIJKE PHILIPS N.V.: PRIMARY MARKET COMPETITORS
FIGURE 70. GE HEALTHCARE: NET SALES, (2021-2023)
FIGURE 71. GE HEALTHCARE: PRIMARY MARKET COMPETITORS
FIGURE 72. SIEMENS HEALTHINEERS: NET SALES, (2021-2023)
FIGURE 73. SIEMENS HEALTHINEERS: PRIMARY MARKET COMPETITORS
FIGURE 74. NIHON KOHDEN CORPORATION: NET SALES, (2021-2023)
FIGURE 75. NIHON KOHDEN CORPORATION: PRIMARY MARKET COMPETITORS
FIGURE 76. ABBOTT LABORATORIES: NET SALES, (2021-2023)
FIGURE 77. ABBOTT LABORATORIES: PRIMARY MARKET COMPETITORS
FIGURE 78. MASIMO CORPORATION: NET SALES, (2021-2023)
FIGURE 79. MASIMO CORPORATION: PRIMARY MARKET COMPETITORS
FIGURE 80. HILL-ROM HOLDINGS, INC.: NET SALES, (2021-2023)
FIGURE 81. HILL-ROM HOLDINGS, INC.: PRIMARY MARKET COMPETITORS
FIGURE 82. BIOTRONIK SE AND CO. KG: NET SALES, (2021-2023)
FIGURE 83. BIOTRONIK SE AND CO. KG: PRIMARY MARKET COMPETITORS
FIGURE 84. HONEYWELL INTERNATIONAL, INC.: NET SALES, (2021-2023)
FIGURE 85. HONEYWELL INTERNATIONAL, INC.: PRIMARY MARKET COMPETITORS